PATENT CLAIM ANALYSIS

Application Number: 16192347
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-09
Patent Classification: ["424", "186100"]

Abstract:
The disclosure provides modified cytomegalovirus (CMV) gL proteins and complexes comprising gL proteins. The modified gL proteins remain intact and are able to form complexes with other CMV proteins.

Claim (Index 21):
The process of  claim 20 , wherein said HCMV complex is a pentameric complex comprising said recombinant HCMV gL protein, or a pentamer-forming fragment thereof, and: an HCMV gH protein or a pentamer-forming fragment thereof, an HCMV pUL128 protein or a pentamer-forming fragment thereof, an HCMV pUL130 protein or a pentamer-forming fragment thereof, and an HCMV pUL131 protein or a pentamer-forming fragment thereof.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 98.0
- Lexical Diversity: 1.5
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15544730', '15522455', '14410461', '15596066', '13409987']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8047296337873496
- 35 USC 102 Novelty (BERT): 0.6123092613600051
- Combined Prediction Score: 0.7854875965446151
- Mean Citation Score: 505.217634
- Max Citation Score: 663.51495
- Similarity Product: 477.59987720702287

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test